Joshua Reed | Chief Financial Officer |
Todd Brady | President & Chief Executive Officer |
Tom Shrader | BTIG |
Justin Kim | Oppenheimer & Company |
Yigal Nochomovitz | Citigroup |
Marc Goodman | SVB Leerink |
Kelly Shi | Jefferies |
Edwin Zhang | H.C. Wainwright |
Prakhar Agrawal | JonesTrading |
Esther Hong | Berenberg |
Yale Jen | Laidlaw & Company |
Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics Third Quarter 2021 Financial Results Conference Call. [Operator Instructions] I would now like to hand over the conference to the company's Chief Financial Officer, Mr. Joshua Reed. Please go ahead, sir.
Good morning, everyone.